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This study presents the first evidence of human
bocavirus infection in South Korean children. The virus was
detected in 27 (8.0%) of 336 tested specimens, including
17 (7.5%) of 225 virus-negative specimens, collected from
children with acute lower respiratory tract infection.
H
uman respiratory syncytial virus (HRSV), human
metapneumovirus (HMPV), parainfluenzavirus, coro-
navirus, and adenovirus are commonly detected viruses in
children with acute lower respiratory tract infections
(LRTI) (1–5). Recently, human bocavirus (HBoV) was
identified as a cause of human respiratory tract infections
in Sweden (6). Although hBoV was initially suspected to
be an important human respiratory pathogen, the world-
wide prevalence and clinical significance of the infection
are still unclear. The purpose of this study was to investi-
gate the prevalence of HBoV infection in children hospi-
talized with acute LRTI in South Korea.
The Study
A total of 336 specimens were evaluated for the pres-
ence of HBoV, including 225 virus-negative specimens
(median age of patients = 14 months; range 1–69 months)
and 111 virus-positive specimens (median age of patients
= 15 months; range 1–83 months). The virus-positive spec-
imens comprised 90 specimens with HRSV, 19 with
HMPV, and 2 with adenovirus and were taken from hospi-
talized children with LRTI at Sanggyepaik Hospital from
July 2004 through October 2005. LRTI included the diag-
noses of bronchiolitis, bronchitis, pneumonia, and laryngo-
tracheobronchitis. The 336 nasopharyngeal samples were
consecutively collected at admission, after informed con-
sent was obtained from the children’s parents. Common
respiratory viruses (HRSV, adenovirus, influenza A and B,
parainfluenza) were detected by direct fluorescent-anti-
body assay kit (Dako Imagen, Cambridgeshire, UK), after
admission. The remaining samples were stored at –70°C
for further studies. Viral RNA was extracted from each
sample by a QIAamp viral RNA mini kit (Qiagen, Hilden,
Germany), and reverse transcription of 0.5 µg of each
RNA sample was performed. Reverse transcription–PCR
was performed to detect HMPV by using F-gene primers
(7) and human coronavirus NL-63, by using a 1-a and a 1-
b primer, as previously described (8).
DNA was extracted from the nasopharyngeal aspirates
with a QIAamp DNA Blood Mini Kit (Qiagen GmbH,
Hilden, Germany). Two PCR assays were performed for
each sample, 1 for the NP1 gene and the other for the NS1
gene, using different primer sets;188F (5′-GACCTCTG-
TAAGTACTATTAC-3′) and 542R (5′-CTCTGT-
GTTGACTGAATACA G-3′) for the NP1 gene; and
HBoV01.2 (5′-TATGGCCAAGGCAATCGTCCAAG-3′)
and HBoV02.2 (5′-GCCGCGTGAACATGAGAAACA-
GA-3′) for the NS1 gene, as previously described (6,9).
Each cycle comprised predenaturation at 95°C for 3 min
and 35 amplification cycles (denaturation at 95°C for 1
min, primer annealing [at 54°C for NP1 gene and 56°C
NS1 gene] for 1 min, and extension at 72°C for 1 min).
The amplified DNA fragments for the NP1 gene and NS1
gene were 354 bp and 291 bp, respectively. To validate the
amplification process and exclude carryover contamina-
tion, positive and negative controls were run for each PCR,
and positive samples were verified against an independent
RNA extraction.
Amplicon was purified by using QIAquick (Qiagen
GmbH) and sequenced in both directions with the BigDye
Terminator v3.1 Cycle Sequencing kit (Applied Bio-
systems, Foster City, CA, USA). Sequencing products
were resolved with an ABI 3730 XLautoanalyzer (Applied
Biosystems). Nucleotides sequences were aligned with
BioEdit v7.0 and presented in a topology tree, prepared in
MEGA 3.1 (10).
Conclusions
This study presents the first evidence of HBoV infec-
tion in Korean children, which suggests that HBoV can
infect humans worldwide (1,2). In this study, HBoV was
detected in 27 (8.0%) of 336 tested specimens and in 17
(7.5%) of 225 virus-negative specimens collected from
children with acute LRTI. A total of 15 (55.6%) of 27
HBoV-positive specimens were obtained from <1-year-old
children, 8 (29.6%) of 27 1- to 2-year-old children, and 4
(14.8%) of 27 3- to 5-year-old children. Other viruses were
also detected in 10 (37%) of 27 HBoV-positive specimens;
5 specimens also contained HRSV, 4 had HMPV, and 1 had
adenovirus. Although HBoV was detected mostly in the
winter in previous studies (6,9), we detected it throughout
the study period.
The medical records of 17 patients with samples posi-
tive for only HBoV were retrospectively reviewed. The
patients ranged in age from 1 to 37 months of age, and the
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of HBoV-positive patients were fever (76.4%), cough
(76.4%), rhinorrhea (23.5%), gastrointestinal symptoms
(11.7%), and rashes (5.8%). Direct sequencing of PCR
products of the NS1 gene and NP1 genes showed that most
strains had the same sequences (Figures 1 and 2). The
prevalence of HBoV in this study was higher than that in
previous studies (3.14%–5.7%). This variation may be due
to differences in the characteristics of the study popula-
tions and collection time of respiratory specimens (6,9,11).
In our study, the positive rates of HBoV in the nasopharyn-
geal aspirates of patients with acute LRTI were relatively
high. However, the clinical role of HBoV is still unclear
because of a high frequency of co-infection (37%), a find-
ing similar to those of previous studies (17.6%–55.6%)
(6,9). In a future study, additional microbial testing for rhi-
novirus and coronaviruses, which are known to cause
LRTIs, is needed to evaluate the precise rate of detection
of >1 virus (12,13).
In conclusion, we confirmed HBoV infection in hospi-
talized children with acute LRTI in South Korea. Further
prospective population-based studies are needed to con-
firm the role of HBoV in LRTI in children.
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Kimura 2-parameter estimation. Nodal confidence values indicate
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